Publication: Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model
1
0
Issued Date
2012
Resource Type
File Type
application/pdf
ISSN
207454
Other identifier(s)
2-s2.0-84859395842
Rights Holder(s)
Scopus
Bibliographic Citation
International Journal of Neuroscience. Vol 122, No.5 (2012), p.263-270
Suggested Citation
Tripanichkul W., Jaroensuppaperch E.-O. Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hydroxydopamine hemiparkinsonian mice model. International Journal of Neuroscience. Vol 122, No.5 (2012), p.263-270. doi:10.3109/00207454.2011.648760 Retrieved from: https://hdl.handle.net/20.500.14740/7067
Author(s)
Abstract
This study investigated the effects of curcumin on nigrostriatal dopaminergic (DA) neurons and glial response in 6-hydroxydopamine (6-OHDA) hemiparkinsonian mice. Following unilateral intrastriatal 6-OHDA injection, mice were daily injected with curcumin for seven days, beginning on the day of lesion. Seven days after 6-OHDA lesioning, sections from the striatum and the substantia nigra pars compacta (SNpc) were collected and immunohistochemically stained for DA neurons and reactive glia. Curcumin decreased 6-OHDA-induced loss of nigral tyrosine hydroxylase-immunoreactive (TH-IR) neurons and striatal TH-IR fibers. The neuroprotection was coincided with a significant attenuation of microglial and astroglial reaction in the SNpc and the striatum. These results suggest that the neuroprotective effects of curcumin in 6-OHDA-lesioned mice may be mediated through its anti-inflammatory properties or direct protection on nigral DA neurons, thereby reducing neuronal injury-induced glial activation. © 2011 Informa Healthcare USA, Inc.
Subject(s)
Curcumin
Oxidopamine
Tyrosine 3 monooxygenase
Animal experiment
Animal model
Animal tissue
Article
Controlled study
Corpus striatum
Dopaminergic nerve cell
Glia
Immunohistochemistry
Immunoreactivity
Macroglia
Male
Mouse
Neuroprotection
Nigroneostriatal system
Nonhuman
Parkinsonism
Substantia nigra
Animals
Corpus Striatum
Curcumin
Disease Models, Animal
Dopaminergic Neurons
Male
Mice
Mice, Inbred ICR
Neural Pathways
Neuroglia
Parkinsonian Disorders
Substantia Nigra
Treatment Outcome
Oxidopamine
Tyrosine 3 monooxygenase
Animal experiment
Animal model
Animal tissue
Article
Controlled study
Corpus striatum
Dopaminergic nerve cell
Glia
Immunohistochemistry
Immunoreactivity
Macroglia
Male
Mouse
Neuroprotection
Nigroneostriatal system
Nonhuman
Parkinsonism
Substantia nigra
Animals
Corpus Striatum
Curcumin
Disease Models, Animal
Dopaminergic Neurons
Male
Mice
Mice, Inbred ICR
Neural Pathways
Neuroglia
Parkinsonian Disorders
Substantia Nigra
Treatment Outcome
